SavedAdd your journal

Journals / Turkish Journal of Gastroenterology / 2012 / Cilt: 23 - Sayı: 6

The prevalence of CYP2C19 mutations in Turkish patients with dyspepsia and influence on H. pylori eradication therapy

Altay ÇELEBİ
Pages
805–806
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

ÇELEBİ, A. (2012). The prevalence of CYP2C19 mutations in Turkish patients with dyspepsia and influence on H. pylori eradication therapy. Turkish Journal of Gastroenterology, Cilt: 23 - Sayı: 6, 805–806. https://ajindex.com/articles/410299

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Ozdil B, Akkiz H, Bayram S, et al. Influence of CYP2C19 functional polymorphism on Helicobacter pylori eradication. Turk J Gastroenterol 2010; 21: 23-8
  2. Celebi A, Kocaman O, Savli H, et al. The prevalence of CYP2C19 mutations in Turkish patients with dyspepsia. Turk J Gastroenterol 2009; 20: 161-4
  3. Grayson ML, Eliopoulos GM, Ferraro MJ, Moellering RC Jr. Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents. Eur J Clin Microbiol Infect Dis 1989; 8: 888-9
  4. Padol S, Yuan Y, Thabane M, et al. The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis. Am J Gastroenterol 2006; 101: 1467-75
  5. Kirchheiner J, Glatt S, Fuhr U, et al. Relative potency of proton-pump inhibitors- comparison of effects on intragastric pH. Eur J Clin Pharmacol 2009; 65: 19-31.